Identity graph
Abvance Therapeutics headquarters, locations and relationships
- Industry
- Healthcare
- Founded
- 2016
- Website
- abvancetherapeutics.com
Abvance Therapeutics office locations
| City | State / region | Country | Type |
|---|---|---|---|
| Reno | Nevada | United States | Headquarters |
- Parent company
- No parent company recorded in GraphIQ.ai.
Verified from public filings, company websites and news · Methodology
Open in GraphIQ.aiMore Abvance Therapeutics data in GraphIQ.ai
This page shows the public record. Sign in with a work email to open the rest of the entity.
-
Technographics (available after sign-in)
Software, cloud and infrastructure in use.
-
Firmographics (available after sign-in)
Revenue, headcount, growth and industry codes.
-
Capabilities (available after sign-in)
Products, services and certifications.
-
News (available after sign-in)
Recent coverage and signals, resolved to the entity.
-
And more (available after sign-in)
Subsidiaries, people and lookalike companies.
Who uses the Abvance Therapeutics entity
-
Revenue and GTM teams
Territories, enrichment and account expansion on one resolved account.
RevOps Sales & marketing -
Industry and supply chain
Suppliers, sites and partners mapped to the right legal entity.
Industry -
Private equity and investors
Corporate family, comparable companies and deal sourcing.
Private equity -
Government and public sector
Supplier vetting, ownership and jurisdiction checks against one verified entity.
Government -
Developers and AI agents
The entity and its relationships through the REST API and MCP server.
Developers
About Abvance Therapeutics
Abvance Therapeutics is headquartered in Reno, Nevada, United States. Founded in 2016, the company employs approximately 5 people worldwide.
Where is Abvance Therapeutics's main office?
Abvance Therapeutics's main headquarters office is located at 38 Bennington Ct., Reno, Nevada 89511, United States. This is the company's primary corporate address.
What does Abvance Therapeutics do?
Traditional insulin replacement therapy involves multiple daily insulin injections or the delivery of insulin by a pump, the need for careful blood glucose monitoring, and the fear of an unwanted fall in blood glucose (hypoglycemia). Fear of hypoglycemia prevents optimal glycemic management leading to long-term hyperglycemia and damage to the body (kidney, heart, extremities). Abvance is a biotechnology company developing a new insulin: glucagon formulation called ABV100 for preventing hypoglycemia. Patients who use ABV100 instead of insulin will experience improved blood glucose control with a safety buffer against hypoglycemia. In addition, ABV100 does not require new behavioral changes or devices and will lighten the daily burden of disease management. ABV100: A titratable, fixed ratio combination of two FDA-approved peptides to control glycemia while mitigating the threat of hypoglycemia.
One entity, every stage
Put Abvance Therapeutics to work across your revenue bowtie
- Target Define the market Build the account list from companies shaped like your best customers, Abvance Therapeutics included. Fingerprint search
- Cover Plan territories Abvance Therapeutics resolves to one account, so it lands in one territory, once. Territory planning
- Engage Act on timing Leadership changes, funding and M&A arrive linked to the account, not a loose headline. Signal monitoring
- Convert Close on a resolved record Inbound and closed-won attach to one CRM record, with no duplicates to merge. CRM enrichment
- Retain Ground every answer Customer teams and AI agents answer from the same entity, with a source and a date. AI agent data layer
- Expand Find the next buyer inside Follow subsidiaries and divisions to the next team that can buy. Account expansion
About the source
What is GraphIQ.ai?
A B2B identity graph. It resolves each organization into one verified entity and maps its parent and subsidiaries, employees, competitors and news signals. Revenue teams use it in the product; AI agents query it through the REST API and MCP server.
POST/api/v2/organizations/search
Abvance Therapeutics: frequently asked questions
Where is Abvance Therapeutics headquarters?
38 Bennington Ct., Reno, Nevada 89511, United States.
When was Abvance Therapeutics founded?
2016.
How many employees does Abvance Therapeutics have?
About 5, as of October 2026 (GraphIQ.ai estimate).
Questions about GraphIQ.ai
Is GraphIQ.ai a list of companies like a spreadsheet?
No. Each organization resolves to one verified entity linked to its parent, subsidiaries, people and signals, so Abvance Therapeutics here is the same Abvance Therapeutics in your CRM, territory plan and agent answers.
Where does this Abvance Therapeutics data come from?
Public filings, company websites and news, resolved to one entity and continuously updated.